| Authors: |
Heinzelmann D; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Reuss F; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Zeh N; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Nilson R; Development Core Technologies, Viral Therapeutics Center, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Walker E; Development Core Technologies, Viral Therapeutics Center, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Fieder J; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Lindner B; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Renner B; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Schulz P; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Fischer S; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany., Schmidt M; Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany. |